Publication Information

{'id': 'https://openalex.org/W2031934837', 'doi': 'https://doi.org/10.1097/inf.0b013e318168b739', 'title': 'Antivirals and Influenza', 'display_name': 'Antivirals and Influenza', 'publication_year': 2008, 'publication_date': '2008-09-26', 'ids': {'openalex': 'https://openalex.org/W2031934837', 'doi': 'https://doi.org/10.1097/inf.0b013e318168b739', 'mag': '2031934837', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/18820569'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/inf.0b013e318168b739', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S109369870', 'display_name': 'The Pediatric Infectious Disease Journal', 'issn_l': '0891-3668', 'issn': ['0891-3668', '1532-0987'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://doi.org/10.1097/inf.0b013e318168b739', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5007966612', 'display_name': 'Arnold S. Monto', 'orcid': 'https://orcid.org/0000-0003-3018-435X'}, 'institutions': [{'id': 'https://openalex.org/I4210099842', 'display_name': 'GlaxoSmithKline (India)', 'ror': 'https://ror.org/01tvt4d48', 'country_code': 'IN', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210099842']}, {'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}, {'id': 'https://openalex.org/I27837315', 'display_name': 'University of Michigan–Ann Arbor', 'ror': 'https://ror.org/00jmfr291', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I27837315']}], 'countries': ['CH', 'IN', 'US'], 'is_corresponding': True, 'raw_author_name': 'Arnold S. Monto', 'raw_affiliation_strings': ['Disclosure: The author has received honoraria from Roche and GlaxoSmithKline.', 'From the Department of Epidemiology, University of Michigan, Ann Arbor, MI.', 'Supported by NIH Cooperative Agreement U01AI057853.'], 'affiliations': [{'raw_affiliation_string': 'Supported by NIH Cooperative Agreement U01AI057853.', 'institution_ids': []}, {'raw_affiliation_string': 'Disclosure: The author has received honoraria from Roche and GlaxoSmithKline.', 'institution_ids': ['https://openalex.org/I4210099842', 'https://openalex.org/I118019719']}, {'raw_affiliation_string': 'From the Department of Epidemiology, University of Michigan, Ann Arbor, MI.', 'institution_ids': ['https://openalex.org/I27837315']}]}], 'institution_assertions': [], 'countries_distinct_count': 3, 'institutions_distinct_count': 3, 'corresponding_author_ids': ['https://openalex.org/A5007966612'], 'corresponding_institution_ids': ['https://openalex.org/I4210099842', 'https://openalex.org/I118019719', 'https://openalex.org/I27837315'], 'apc_list': None, 'apc_paid': None, 'fwci': 3.197, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 25, 'citation_normalized_percentile': {'value': 0.748419, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': '27', 'issue': '10', 'first_page': 'S110', 'last_page': 'S112'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10167', 'display_name': 'Influenza Virus Research Studies', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10167', 'display_name': 'Influenza Virus Research Studies', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11243', 'display_name': 'Respiratory viral infections research', 'score': 0.9887, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13201', 'display_name': 'Infectious Encephalopathies and Encephalitis', 'score': 0.9552, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/rimantadine', 'display_name': 'Rimantadine', 'score': 0.9650285}, {'id': 'https://openalex.org/keywords/zanamivir', 'display_name': 'Zanamivir', 'score': 0.92463034}, {'id': 'https://openalex.org/keywords/oseltamivir', 'display_name': 'Oseltamivir', 'score': 0.87870514}, {'id': 'https://openalex.org/keywords/amantadine', 'display_name': 'Amantadine', 'score': 0.85917866}, {'id': 'https://openalex.org/keywords/neuraminidase-inhibitor', 'display_name': 'Neuraminidase inhibitor', 'score': 0.73887336}, {'id': 'https://openalex.org/keywords/pandemic', 'display_name': 'Pandemic', 'score': 0.49748543}], 'concepts': [{'id': 'https://openalex.org/C2780391423', 'wikidata': 'https://www.wikidata.org/wiki/Q42171', 'display_name': 'Rimantadine', 'level': 4, 'score': 0.9650285}, {'id': 'https://openalex.org/C2781442963', 'wikidata': 'https://www.wikidata.org/wiki/Q146075', 'display_name': 'Zanamivir', 'level': 5, 'score': 0.92463034}, {'id': 'https://openalex.org/C2780374985', 'wikidata': 'https://www.wikidata.org/wiki/Q211509', 'display_name': 'Oseltamivir', 'level': 5, 'score': 0.87870514}, {'id': 'https://openalex.org/C2777374534', 'wikidata': 'https://www.wikidata.org/wiki/Q409761', 'display_name': 'Amantadine', 'level': 2, 'score': 0.85917866}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.85729843}, {'id': 'https://openalex.org/C134164806', 'wikidata': 'https://www.wikidata.org/wiki/Q409485', 'display_name': 'Neuraminidase', 'level': 3, 'score': 0.7580446}, {'id': 'https://openalex.org/C2777538117', 'wikidata': 'https://www.wikidata.org/wiki/Q425196', 'display_name': 'Neuraminidase inhibitor', 'level': 5, 'score': 0.73887336}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.5162135}, {'id': 'https://openalex.org/C89623803', 'wikidata': 'https://www.wikidata.org/wiki/Q12184', 'display_name': 'Pandemic', 'level': 5, 'score': 0.49748543}, {'id': 'https://openalex.org/C114851261', 'wikidata': 'https://www.wikidata.org/wiki/Q12147416', 'display_name': 'Drug resistance', 'level': 2, 'score': 0.4186296}, {'id': 'https://openalex.org/C2777546802', 'wikidata': 'https://www.wikidata.org/wiki/Q834390', 'display_name': 'Influenza A virus', 'level': 3, 'score': 0.3990727}, {'id': 'https://openalex.org/C2522874641', 'wikidata': 'https://www.wikidata.org/wiki/Q808', 'display_name': 'Virus', 'level': 2, 'score': 0.3566985}, {'id': 'https://openalex.org/C177713679', 'wikidata': 'https://www.wikidata.org/wiki/Q679690', 'display_name': 'Intensive care medicine', 'level': 1, 'score': 0.32579637}, {'id': 'https://openalex.org/C3008058167', 'wikidata': 'https://www.wikidata.org/wiki/Q84263196', 'display_name': 'Coronavirus disease 2019 (COVID-19)', 'level': 4, 'score': 0.27232248}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.18419692}, {'id': 'https://openalex.org/C89423630', 'wikidata': 'https://www.wikidata.org/wiki/Q7193', 'display_name': 'Microbiology', 'level': 1, 'score': 0.1802316}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.115018934}, {'id': 'https://openalex.org/C524204448', 'wikidata': 'https://www.wikidata.org/wiki/Q788926', 'display_name': 'Infectious disease (medical specialty)', 'level': 3, 'score': 0.104386955}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.08820221}], 'mesh': [{'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D024882', 'descriptor_name': 'Drug Resistance, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D009980', 'descriptor_name': 'Influenza A virus', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D009981', 'descriptor_name': 'Influenza B virus', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D007251', 'descriptor_name': 'Influenza, Human', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000547', 'descriptor_name': 'Amantadine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000547', 'descriptor_name': 'Amantadine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000547', 'descriptor_name': 'Amantadine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004196', 'descriptor_name': 'Disease Outbreaks', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D053124', 'descriptor_name': 'Influenza A Virus, H5N1 Subtype', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D053124', 'descriptor_name': 'Influenza A Virus, H5N1 Subtype', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009980', 'descriptor_name': 'Influenza A virus', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009981', 'descriptor_name': 'Influenza B virus', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007251', 'descriptor_name': 'Influenza, Human', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D007251', 'descriptor_name': 'Influenza, Human', 'qualifier_ui': 'Q000517', 'qualifier_name': 'prevention & control', 'is_major_topic': False}, {'descriptor_ui': 'D007251', 'descriptor_name': 'Influenza, Human', 'qualifier_ui': 'Q000821', 'qualifier_name': 'virology', 'is_major_topic': False}, {'descriptor_ui': 'D007251', 'descriptor_name': 'Influenza, Human', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009439', 'descriptor_name': 'Neuraminidase', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D009439', 'descriptor_name': 'Neuraminidase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D053139', 'descriptor_name': 'Oseltamivir', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D053139', 'descriptor_name': 'Oseltamivir', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D053139', 'descriptor_name': 'Oseltamivir', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012299', 'descriptor_name': 'Rimantadine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D012299', 'descriptor_name': 'Rimantadine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D012299', 'descriptor_name': 'Rimantadine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D053243', 'descriptor_name': 'Zanamivir', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D053243', 'descriptor_name': 'Zanamivir', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D053243', 'descriptor_name': 'Zanamivir', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 3, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/inf.0b013e318168b739', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S109369870', 'display_name': 'The Pediatric Infectious Disease Journal', 'issn_l': '0891-3668', 'issn': ['0891-3668', '1532-0987'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://journals.lww.com/pidj/Fulltext/2008/10001/Antivirals_and_Influenza__Frequency_of_Resistance.15.aspx', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/18820569', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/inf.0b013e318168b739', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S109369870', 'display_name': 'The Pediatric Infectious Disease Journal', 'issn_l': '0891-3668', 'issn': ['0891-3668', '1532-0987'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.87, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 23, 'referenced_works': ['https://openalex.org/W1926501982', 'https://openalex.org/W1981513529', 'https://openalex.org/W2000693418', 'https://openalex.org/W2002335181', 'https://openalex.org/W2027368298', 'https://openalex.org/W2029292325', 'https://openalex.org/W2036255405', 'https://openalex.org/W2045197177', 'https://openalex.org/W2046938649', 'https://openalex.org/W2047260093', 'https://openalex.org/W2075704126', 'https://openalex.org/W2084087100', 'https://openalex.org/W2092237993', 'https://openalex.org/W2097680721', 'https://openalex.org/W2117004115', 'https://openalex.org/W2129482297', 'https://openalex.org/W2130441728', 'https://openalex.org/W2147642881', 'https://openalex.org/W2149087734', 'https://openalex.org/W2157177671', 'https://openalex.org/W2162695199', 'https://openalex.org/W2315523527', 'https://openalex.org/W2316425515'], 'related_works': ['https://openalex.org/W4378840820', 'https://openalex.org/W2633870859', 'https://openalex.org/W2587129805', 'https://openalex.org/W2168374267', 'https://openalex.org/W2154030535', 'https://openalex.org/W2129882416', 'https://openalex.org/W2083059803', 'https://openalex.org/W2080927210', 'https://openalex.org/W1999703541', 'https://openalex.org/W1971263083'], 'abstract_inverted_index': {'Antivirals': [0], 'are': [1, 10, 41, 52, 129], 'effective': [2], 'in': [3, 43, 66, 77, 143], 'prophylaxis': [4, 67], 'and': [5, 9, 29, 31, 37, 88, 95, 114, 168], 'therapy': [6, 78], 'for': [7, 121], 'influenza': [8, 123], 'likely': [11], 'to': [12, 45, 172, 180], 'be': [13, 22, 146, 181], 'active': [14, 54, 130], 'against': [15, 55, 131], 'a': [16], 'new': [17], 'pandemic': [18], 'variant.': [19], 'They': [20, 128], 'can': [21], 'divided': [23], 'into': [24], 'the': [25, 32, 50, 141, 154, 159], 'M2': [26, 74, 160], 'inhibitors,': [27], 'adamantane': [28], 'rimantadine,': [30], 'neuraminidase': [33], 'inhibitors': [34, 75], '(NAIs),': [35], 'zanamivir': [36], 'oseltamivir.': [38], 'The': [39, 102], 'former': [40], 'limited': [42, 80], 'activity': [44], 'type': [46, 56], 'A': [47], 'viruses,': [48], 'whereas': [49], 'latter': [51], 'also': [53, 89, 164], 'B': [57], 'viruses.': [58], 'Both': [59], 'classes': [60], 'of': [61, 73, 92, 97, 100, 107, 112], 'drugs': [62], 'appear': [63, 165], 'similarly': [64], 'efficacious': [65], 'at': [68, 153], 'approximately': [69], '70-90%.': [70], 'However,': [71, 174], 'use': [72, 120, 176], '(adamantanes)': [76], 'is': [79], 'by': [81, 90], 'side': [82], 'effects,': [83], 'more': [84], 'common': [85], 'with': [86, 158], 'amantadine,': [87], 'production': [91], 'antiviral': [93], 'resistance': [94, 178], 'lack': [96], 'demonstrated': [98], 'prevention': [99], 'complications.': [101, 116], 'NAIs': [103], 'prevent': [104], 'both': [105], 'types': [106], 'seasonal': [108, 122], 'influenza,': [109], 'shorten': [110], 'duration': [111], 'illness,': [113], 'reduce': [115], 'As': [117], 'such,': [118], 'their': [119], 'treatment': [124], 'has': [125, 135], 'been': [126, 136], 'increasing.': [127], 'A(H5N1)': [132], 'but': [133, 151], 'oseltamivir': [134], 'most': [137], 'extensively': [138], 'stockpiled': [139], 'because': [140], 'infection': [142], 'humans': [144], 'may': [145], 'disseminated.': [147], 'Resistance': [148], 'does': [149], 'emerge,': [150], 'not': [152], 'same': [155], 'frequency': [156], 'as': [157, 175], 'inhibitors.': [161], 'Resistant': [162], 'viruses': [163], 'less': [166, 170], 'fit': [167], 'thus': [169], 'able': [171], 'spread.': [173], 'increases,': [177], 'needs': [179], 'carefully': [182], 'monitored.': [183]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2031934837', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 3}, {'year': 2013, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 2}], 'updated_date': '2024-12-10T11:48:26.695579', 'created_date': '2016-06-24'}